ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Kaiser Aluminum shares rise 4.4% after UBS upgrade to Buy

UBS lifts Kaiser Aluminum to Buy from Neutral with a $184 price target, citing strong EBITDA growth and operational improvements. Shares had fallen 19% since August.

PA
Priya Anand · Equities & Earnings Desk · 2 Sept 2026 · 04:46 · 1 min read
Share
Kaiser Aluminum shares rise 4.4% after UBS upgrade to Buy

Kaiser Aluminum Corporation’s stock rose 4.4% on Monday after UBS upgraded the company to Buy from Neutral, citing improving fundamentals and operational momentum.

The upgrade follows a 19% decline in the company’s shares since August, driven by concerns over U.S.-Mexico-Canada Agreement renegotiations, a CEO transition, and uncertainty around scrap spread sustainability. UBS analyst Alex Stansbury raised the price target to $184 from $179, emphasizing Kaiser Aluminum’s second-quarter fiscal 2026 EBITDA growth of approximately $41 million, a 60% year-over-year increase.

UBS projects over 50% EBITDA growth for fiscal 2026, with the firm estimating a 66% increase. The stock’s valuation has de-rated to roughly 7.5x UBS’ estimated EV/EBITDA, below the historical average of 8.6x. Stansbury noted that the recent selloff presents an attractive entry point, as underlying fundamentals strengthen despite lingering scrap-related tailwinds.

The analyst highlighted ongoing benefits from investments at the Warrick and Trentwood facilities, alongside the end of aerospace destocking as build rates accelerate. UBS expects these factors to support continued earnings growth, reinforcing the upgrade to Buy.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT